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Ryanodine Receptors Are Expressed in Epidermal
Keratinocytes and Associated with Keratinocyte
Differentiation and Epidermal Permeability
Barrier Homeostasis
Sumiko Denda1,2, Junichi Kumamoto2, Kentaro Takei1, Moe Tsutsumi1,2, Hirofumi Aoki1
and Mitsuhiro Denda1,2
Ryanodine receptors (RyRs) have an important role as calcium channels in the regulation of intracellular calcium
levels in the nervous system and muscle. In the present study, we investigated the expression of RyR in human
epidermis. Immunohistochemical studies and reverse transcription-PCR indicated the expression of RyR type 1,
2, and 3 proteins in epidermal keratinocytes. The expression level of each RyR subtype was higher in
differentiating keratinocytes than in proliferative cells. We also demonstrated the functional expression of RyR
by calcium imaging. In cultured human keratinocytes, application of the RyR agonist 4-chloro-m-cresol (CMC)
induced elevation of the intracellular calcium concentration, and co-application of the RyR antagonist 1,10-
diheptyl-4,40-bipyridinium dibromide (DHBP) blocked the elevation. Application of CMC accelerated
keratinocyte differentiation in vitro. On the other hand, topical application of CMC after tape-stripping of
hairless mouse skin delayed barrier recovery, whereas application of an RyR antagonist, dantrolene or DHBP,
accelerated the barrier recovery. These results suggest that RyR expressed in epidermal keratinocytes is
associated with both differentiation of keratinocytes and epidermal barrier homeostasis.
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INTRODUCTION
Calcium dynamics in epidermal keratinocytes has key roles
in keratinocyte differentiation and water-impermeable barrier
homeostasis. We have previously shown that various
neurotransmitter receptors are expressed in epidermal kera-
tinocytes (Denda et al., 2007b). Activation of excitatory
receptors, such as N-methyl-D-aspartate receptor, nicotinic
acetylcholine receptor, and P2X3 receptor, induces calcium
influx and delays barrier recovery (Denda et al., 2002, 2003a;
Fuziwara et al., 2003). Application of a calcium ionophore,
which also induces calcium influx, also delayed barrier
recovery (Denda et al., 2003a). These results suggest that
elevation of intracellular calcium concentration in epidermal
keratinocytes delays barrier recovery.
The excitatory receptors mentioned above are expressed
in the cell membrane and serve to regulate the intracellular
calcium level. On the other hand, the endoplasmic reticulum
(ER) also has an important role as a calcium store and
regulates calcium signaling in many types of cells. IP3
receptor and ryanodine receptor (RyR) are the major calcium
channels mediating calcium-induced calcium release
(Berridge et al., 2000).
It has been shown that IP3 receptor is associated with
TRPV3 signaling in mouse keratinocytes (Cheng et al., 2010).
We recently demonstrated that IP3 had an important role
in calcium propagation in cultured human keratinocytes
(Tsutsumi et al., 2010). RyR is expressed in the ER or
sarcoplasmic reticulum in muscle. Three RyR subtypes have
been described, and many cell types are known to express each
of them. Their roles have only been extensively characterized
in tissues in which they are abundant: RyR1 is essential for
excitation–contraction coupling in the skeletal muscle, whereas
RyR2 is essential in the cardiac muscle. RyR2 and RyR3 have
roles in intracellular calcium regulation in the brain (Zucchi
and Ronca-Testoni, 1997; Kushnir et al., 2010). As mentioned
above, there are similarities of receptor expression between
neurons and keratinocytes, both of which are derived from the
ectoderm during the early stage of development. Thus, we
hypothesized that RyR might be expressed in epidermal
keratinocytes and be associated with cellular differentiation
and/or epidermal permeability barrier homeostasis.
In the present study, we first examined whether or not
RyR is present in epidermal keratinocytes by means of
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immunohistochemistry and reverse transcription-PCR. Then,
we evaluated the response of intracellular calcium to RyR
modulators. We also examined the effects of these modula-
tors on keratinocyte differentiation. Finally, we studied the
effects of topical application of these modulators on the
recovery process after barrier disruption.
RESULTS
Immunoreactivity to RyR antibodies was observed in the
epidermis of human skin (Figure 1). RyR1 was expressed
strongly in the differentiated layers of the epidermis. RyR2
was also expressed in the differentiated layers, especially in
the border layer between the stratum corneum and the
granular layer. RyR3 was expressed throughout the epider-
mis, but the expression was stronger in the differentiated
layers than in the basal layer. Conventional reverse transcrip-
tion-PCR analysis showed that mRNAs for all RyR subtypes,
including the two alternative splice variants of RyR3, were
present in human skin and cultured epidermal keratinocytes
(Figure 2). Quantitative PCR analysis revealed that expression
of all RyR subtypes in cultured keratinocytes was dramati-
cally increased after the induction of differentiation by high
Ca2þ (Figure 3). This result is consistent with the character-
istic distribution in vivo (Figure 1).
Functional activity of RyRs in keratinocytes was confirmed
by studying changes in intracellular free calcium concentra-
tion ([Ca2þ ]i) in response to RyR modulators (Figure 4). In
a Ca2þ -free bath solution, application of an RyR agonist,
4-chloro-m-cresol (CMC; Ducreux et al., 2004), induced
elevation of [Ca2þ ]i (Figure 4a), and the elevation was
inhibited by an RyR antagonist, 1,10-diheptyl-4,40-bipyridi-
nium dibromide (DHBP; Lauckner et al., 2005; Figure 4b,
second stimulation). The CMC response disappeared when
intracellular Ca2þ was chelated with BAPTA-AM (Figure 4c).
Although the CMC response, expressed as change of
fluorescence ratio, was smaller than the ionomycin response
(Figure 4e), it was comparable with the thapsigargin response
(Figure 4d). Thapsigargin releases Ca2þ from the ER store by
RyR1 RyR2 RyR3
Figure 1. Immunohistochemical study of human skin with ryanodine receptor (RyR) antibodies. (a, d, g) Anti-RyR1 (red); (b, e, h) anti-RyR2 (red); (c, f, i) anti-
RyR3 (red); (d, e, f) merged with anti-involucrin (green) and differential interference contrast image to observe the unstained stratum corneum; (g, h, i) merged
with anti-keratin 14 (green) to observe the basal layer of the epidermis; (j, k, l) without primary antibodies. RyR was observed in the epidermis with
distinct subtype distribution patterns. Bar¼ 20mm.
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inhibiting sarco/endoplasmic Ca2þ -ATPase (Thastrup et al.,
1990). Therefore, the elevation of [Ca2þ ]i by CMC appears to
depend on Ca2þ release from the intracellular calcium store,
via the opening of the RyR channel.
As the abundance of RyR in differentiated keratinocytes
suggests a role in epidermal differentiation, we next studied
the effects of the RyR agonist CMC on the expression of
differentiation marker genes in keratinocytes (Figure 5a and b).
Involucrin is a component of cornified envelope (CE), which
is the product of terminal differentiation of keratinocytes, and
transglutaminase 3 is specifically expressed in the granular
layers of the epidermis, where it is activated by [Ca2þ ]i
elevation to function for CE formation (Candi et al., 2005). In
undifferentiated keratinocytes, CMC increased the mRNA
expression of both genes. In keratinocytes, just after the
induction of differentiation with high Ca2þ , the RyR
antagonists DHBP and dantrolene (Mackrill, 2010) both
inhibited involucrin expression (Figure 5c). The promoting
RyR1
1 2 3 4 5 6 7
RyR2
RyR3
(2 variants)
GAPDH
Figure 2. Detection of ryanodine receptor (RyR) expression by reverse
transcription-PCR. Lane 1, skeletal muscle (positive control for RyR1); lane 2,
heart (positive control for RyR2); lane 3, brain (positive control for all
RyRs); lane 4, skin; lane 5, proliferative keratinocytes; lane 6, differentiating
keratinocytes (2 days after induction); and lane 7, differentiating keratinocytes
(4 days after induction). The PCR product sizes for RyR1 and RyR2 were 251
and 290 bp, respectively. The PCR for RyR3 detected two alternative splice
variants (152 and 234 bp), as reported (Klegeris et al., 2007). GAPDH,
glyceraldehyde-3-phosphate dehydrogenase.
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Figure 3. Changes in the expression of ryanodine receptor (RyR) subtype
mRNAs in differentiating keratinocytes. RyR mRNA levels were measured by
quantitative PCR. Expression levels of each subtype of RyR and involucrin
(as a differentiation marker) were increased in differentiating keratinocytes.
Asterisks denote statistical significance as compared with Pro (n¼ 3).
*Po0.05, **Po0.01, ***Po0.001. D1, differentiating keratinocytes (1 day
after induction); D2, differentiating keratinocytes (2 days after induction);
HPRT1, hypoxanthine phosphoribosyl transferase 1; Pro, proliferative
keratinocytes.
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Figure 4. Calcium imaging of keratinocytes. Normal human epidermal
keratinocytes were treated with the indicated reagents, in a Ca2þ -free (a–d) or
0.06mM Ca2þ -containing (e) bath solution. Almost 100% of the cells in the
microscopic field responded to the reagents. Representative profiles of fura-2
ratio (F340/F380) in a single cell are shown. Experiments were repeated three
times with similar results. (a) A ryanodine receptor (RyR) agonist, 4-chloro-
m-cresol (CMC, 0.5mM), was applied twice, each for 3minutes. (b) For the
second CMC stimulation, a RyR antagonist, 1,10-diheptyl-4,40-bipyridinium
dibromide (DHBP, 100mM), was also applied. (c) Cells were preincubated for
30minutes with 50 mM BAPTA-AM in the medium, and then CMC was
applied. (d) CMC was applied first, and then thapsigargin (100 nM) was
applied to observe the response when Ca2þ is released from the endoplasmic
reticulum store. (e) Ionomycin (10mM) was applied to obtain the maximal
response. Application of CMC induced the elevation of [Ca2þ ]i, and this
action was inhibited by DHBP. These results show that RyR is functional in
keratinocytes.
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activity of CMC and inhibiting activity of DHBP on cellular
differentiation were further supported by analysis of CE
(Figure 5d). In the presence of high Ca2þ , the percentage of
cells containing CE was increased after incubation with CMC,
but this increase was blocked when DHBP was co-applied
with CMC. DHBP alone inhibited CE formation. These results
indicate that the elevation of [Ca2þ ]i by the RyR agonist may
induce the synthesis of mRNAs and proteins for CE
constituents, and also activate enzymes, such as transgluta-
minase 3, necessary for CE formation. As RyR antagonists
inhibited differentiation induced by high Ca2þ , RyR may be
involved in Ca2þ signal amplification and/or homeostatis
after the elevation of extracellular Ca2þ .
The effects of topical application of RyR agonist and
antagonists on the barrier recovery rate after barrier disrup-
tion are shown in Figure 6. Application of the agonist CMC
significantly delayed barrier recovery, whereas application of
an antagonist, dantrolene or DHBP, accelerated barrier
recovery.
DISCUSSION
We previously reported that activation of calcium-permeable
channels on the keratinocyte cell membrane delayed the
recovery after barrier disruption (Fuziwara et al., 2003;
Denda et al., 2003a). Moreover, activation of some G
protein-coupled receptors, such as adrenergic receptors, also
induced the elevation of intracellular calcium via voltage-
gated calcium channels and delayed the barrier recovery
(Denda et al., 2003b; Denda et al., 2004; Fuziwara et al.,
2005). That is, activation of excitatory receptors in keratino-
cytes delayed the barrier recovery. In these cases, intracel-
lular calcium elevation is induced by influx of calcium ions
from outside the cells.
In nerve cells or muscle cells, excitation (i.e., depolariza-
tion) is also induced by calcium ion release from the ER.
However, there are few reports on the role of IP3 receptors
and no report on the function of RyRs in epidermal
keratinocytes. In the present study, we have demonstrated
the presence of RyRs in keratinocytes for the first time, and
examined their roles in epidermal differentiation and
epidermal permeability barrier homeostasis.
We detected all of the three known types of RyR, although
we did not clarify which type(s) of RyR were associated with
keratinocyte differentiation and barrier homeostasis. The
mRNA of each receptor increased with keratinocyte differ-
entiation (Figure 3). As RyR1 and RyR2 were localized at the
Involucrin Transglutaminase 3
7 *** *
**
**
***
***
***
0.3
0.2
0.1
0
6
5
4
R
el
at
iv
e 
m
R
N
A 
le
ve
l
(no
rm
ali
ze
d t
o H
PR
T1
)
R
el
at
iv
e 
m
R
N
A 
le
ve
l
(no
rm
ali
ze
d t
o H
PR
T1
)
R
el
at
iv
e 
m
R
N
A 
le
ve
l
(no
rm
ali
ze
d t
o H
PR
T1
)
3
0
Control
Involucrin Cornified envelope
5
3
4
CE
 (%
 of
 to
tal
 ce
lls
)
2
1
0
4
3
2
1
0
Control CMC
DHBP Dantrolene Control DHBP CMC CMC+
DHBP
Control CMC
2
1
Figure 5. Effects of ryanodine receptor (RyR) modulators on keratinocyte
differentiation. (a, b, c) Expression levels of differentiation marker genes
were measured by quantitative PCR after 24 hours incubation. (a, b)
Undifferentiated confluent keratinocytes were treated with 4-chloro-m-cresol
(CMC; 0.3mM) in medium containing 0.06mM CaCl2. CMC increased the
mRNA expression of involucrin and transglutaminase 3. (c) Confluent
keratinocytes were treated with 1,10-diheptyl-4,40-bipyridinium dibromide
(DHBP; 45mM) or dantrolene (45 mM), at the same time as induction of
differentiation with high Ca2þ . Both RyR antagonists inhibited involucrin
expression. (d) Cornified envelope (CE), the product of terminal differentiation
of keratinocytes, was counted after a 4-day incubation with the reagents.
The total cell number at harvest was 2–4 106 cells per well. The CE was
increased in the presence of CMC (0.3mM), and the increase was abolished
when DHBP (15 mM) was co-applied with CMC. DHBP alone inhibited the
CE formation. Asterisks denote statistical significance (n¼ 3). *Po0.05,
**Po0.01, ***Po0.001. HPRT1, hypoxanthine phosphoribosyl transferase 1.
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Figure 6. Effects of topical application of ryanodine receptor (RyR)
modulators on the barrier recovery rate of the skin. A RyR agonist, 4-chloro-
m-cresol (CMC; 2.5mM), delayed the barrier recovery after tape-stripping,
whereas RyR antagonists, dantrolene (DA; 100 mM) and 1,10-diheptyl-4,40-
bipyridinium dibromide (DHBP; 250mM), accelerated the recovery. NS, not
significant.
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uppermost layer of the epidermis (Figure 1), they may have a
role in barrier homeostasis. To our knowledge, among RyR
gene-targeted mice, only RyR1I4895T homozygous mutant
mice are reported to have a phenotype in skin. They die
perinatally because of asphyxia, and the skin of the neonates
exhibits a marked delay in dermatogenesis, showing a
severely underdeveloped dermis with a very thin layer of
relatively undifferentiated epidermis and poorly defined hair
follicles (Zvaritch et al., 2007). The RyR1-mediated Ca2þ
release might also be important for skin development.
Calcium release from the ER induces calcium waves or
calcium oscillations (Berridge et al., 2000). We previously
demonstrated that air exposure of cultured human keratino-
cytes also induced calcium waves and calcium oscillations
(Denda and Denda, 2007a). RyR in the keratinocytes might
be associated with these calcium dynamics in the epidermis.
There is a calcium gradient in the epidermis (Mauro, 1998;
Denda et al., 2000a), with the highest level of calcium ion in
the uppermost layer. Immediately after barrier insult, the
gradient disappears, and with recovery of the barrier function
the calcium gradient also recovers. Occlusion with a water-
impermeable membrane perturbs the barrier recovery and the
calcium gradient is not restored (Menon et al., 1994). Thus,
calcium dynamics in the epidermis seems to have a central
role in barrier homeostasis. The calcium gradient is also
significantly related to keratinocyte differentiation in the
epidermis (Elias et al., 2002). Recently, Celli et al. (2010)
showed that barrier disruption by tape-stripping resulted in
the activation of ER-stress-induced transcription factor XBP1.
Our findings suggest that RyR in the epidermis might have an
important role in these processes.
In the brain, RyR has a role in the secretion of oxytocin (Jin
et al., 2007). We previously demonstrated that various
neurotransmitters, such as ATP, glutamate, and dopamine,
were released from the epidermis after barrier insult (Denda
et al., 2002; Fuziwara et al., 2003, 2005). Therefore, RyR
might be associated with the secretion of these molecules.
In the present study, we have demonstrated the functional
existence of RyR in epidermal keratinocytes, and we have
shown that RyR modulators influence keratinocyte differ-
entiation and barrier homeostasis. Although the mechanism
of calcium-induced calcium release by RyR in keratinocytes
remains to be clarified, RyR could be an new target for
research on dermatological diseases.
MATERIALS AND METHODS
Materials
CMC, DHBP, and dantrolene sodium salt were purchased from
Sigma-Aldrich (St Louis, MO). Human tissue was obtained following
plastic surgery, after informed consent had been obtained. This study
was approved by the Ethics Committee of Shiseido Research Center in
accordance with the guideline of the National Institute of Health, and
was conducted according to the Declaration of Helsinki Principles.
Immunohistochemistry
Frozen sections of human skin were fixed with cold methanol
and reacted with specific antibodies at 4 1C overnight, then
visualized with Alexa 594- or 488-conjugated secondary antibodies
(Invitrogen, Carlsbad, CA). The sections were counter-stained
with Hoechst 33258 for nuclear staining. The following antibodies
were used: anti-RyR1 (Millipore, Billerica, MA, no. AB9078,
rabbit polyclonal, at 1:2,000 dilution), anti-RyR2 (Millipore, no.
AB9080, rabbit polyclonal, 1:1,000), anti-RyR3 (Santa Cruz
Biotechnology, Santa Cruz, CA, no. sc-21330, goat polyclonal,
1:50), anti-keratin 14 (Millipore, no. MAB3232, 1:2,000), anti-
involucrin (Novocastra/Leica, Wetzlar, Germany, clone SY5, 1:800).
The subtype-specific characteristics of these RyR antibodies have
been reported (Dabertrand et al., 2007; Medina-Ortiz et al., 2007).
Culture of keratinocytes
Normal human epidermal keratinocytes (NHEKs) were purchased
from Kurabo (Osaka, Japan). NHEKs were cultured in Epilife-KG2
medium (Kurabo) containing 0.06mM CaCl2. NHEKs (passage 3–4)
were seeded onto collagen-coated glass coverslips and used for
calcium imaging at 60–80% confluency. For RNA preparation, cells
were grown in six-well plates and harvested in the proliferative state
(60–80% confluency) or the differentiated state. Cell differentiation
was induced at 100% confluency by increasing the calcium
concentration to 1.8mM in the medium (Kolly et al., 2005), and
differentiated cells were harvested 1–4 days after the induction.
Reverse transcription-PCR
Total RNA was isolated from human keratinocytes using EZ1 RNA
cell mini kit (Qiagen GmbH, Hilden, Germany), then 1 mg of total
RNA was reverse-transcribed with Superscript III (Invitrogen) in a
final volume of 20 ml. Human skin complementary DNA was
purchased from BioChain (Hayward, CA). Human complementary
DNAs from brain, skeletal muscle, and heart were purchased from
Takara Bio (Otsu, Japan). Conventional PCR was performed using
the RyR type-specific primers (Klegeris et al., 2007). PCR reac-
tion was performed for 38 cycles, with annealing at 55 1C. PCR
for GAPDH gene (forward 50-CCCATCACCATCTTCCAG-30, reverse
50-CCTGCTTCACCACCTTCT-30, 577 bp product) was performed
as a loading control. RyR mRNAs were measured by real-time
quantitative PCR using Universal Probe Library (UPL) probes and
primers designed by UPL Assay Design software, in the LightCycler
480 instrument (Roche Diagnostics GmbH, Mannheim, Germany).
The following primers and UPL probes were used: human hypo-
xanthine phosphoribosyl transferase 1 forward 50-TGACCTTGATTT
ATTTTGCATACC-30, reverse 50-CGAGCAAGACGTTCAGTCCT-30,
UPL 73; RyR1 forward 50-CCTGTGCTCAAGCTCGTGT-30, reverse
50-CACATCCTCATCGCCAAAG-30, UPL 9; RyR2 forward 50-GATGA
AACAGAACACACAGGACA-30, reverse 50-TTTAGCTGGTCTTCATA
CTGTTTCC-30, UPL 3; RyR3 forward 50-CCTGGATGATGCTTCAAT
GAT-30, reverse 50-ATAGACCCAGACAGCAGATGG-30, UPL 24;
involucrin forward 50-GGAGAAGCAGGAGGCACA-30, reverse
50-TCCAGGTGCTTTGGCTGT-30, UPL 62; transglutaminase 3 for-
ward 50-ATTGGCTGGAACTTTGGACA-30, reverse 50-GGCGGAAA
TTCAGACTCCTA-30, UPL 34. Hypoxanthine phosphoribosyl trans-
ferase 1 gene expression level was used for data normalization.
Quantification of gene expression was carried out by the compara-
tive Ct method.
Ca2þ imaging in single keratinocytes
Cells were incubated with 5mM fura-2, AM (Invitrogen) for 1 hour at
37 1C. The fura-2-loaded cells were placed on the stage of an
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inverted fluorescence microscope (Ti, Nikon) and perfused
with Ca2þ -free bath solution (150mM NaCl, 5mM KCl, 1.2mM
MgCl2, 1.2mM NaH2PO4, 10mM HEPES (4-(2-hyroxyethyl)-1-pipera-
zine ethane sulfonic acid), 1mM EGTA, and 10mM D-glucose
(pH 7.4)). Image capture and processing were performed using an
ORCA-R2 CCD camera and Aquacosmos software (Hamamatsu
Photonics, Hamamatsu, Japan). With alternating illumination at
340 and 380 nm for excitation, pairs of fluorescence images
were obtained every 2 seconds through an objective lens (S Fluor
 10/0.50 numerical aperture, Nikon) and an emission filter
(470–550 nm). Changes in [Ca2þ ]i of single cells were displayed as
fura-2 ratio (F340/F380).
Analysis of cornified envelope
Keratinocytes were grown in six-well plates. At 100% confluency,
the cells were treated with reagents in a medium containing 1.8mM
CaCl2, and incubation was continued for 4 days. The medium
containing the reagent was changed every day. Then the cells were
trypsinized and counted. CEs were prepared as described (Sun and
Green, 1976). Briefly, a known number of trypsinized cells was
resuspended in a buffer consisting of 10mM Tris–HCl, pH 7.5, 1%
2-mercaptoethanol, and 1% SDS, and incubated at 80 1C until the
plasma membrane was dissolved. The remaining CEs were counted
using a hemocytometer.
Barrier recovery
Permeability barrier function was evaluated by measurement of
transepidermal water loss (TEWL) with an electric moisture analyzer
(Meeco, Warrington, PA), as described previously (Denda et al.,
1998). All experiments were performed on 7- to 10-week-old male
hairless mice (HR-1, Hoshino, Japan). The measurement of skin
barrier function, disruption of the barrier, and application of the test
sample were carried out under anesthesia with nembutal. For barrier
recovery experiments, skin on both flanks was treated by repeated
tape-stripping until the TEWL reached 7–10mg cm2 per hour, as
described previously (Denda et al., 1998). Immediately after tape-
stripping, a solution of each reagent was applied on the skin (100 ml
per one side of the flank). For aqueous solution, the skin surface
treated with the solution was covered with a plastic wrap for
20minutes to aid absorption. Two points were measured per flank
and eight mice were used to evaluate the effects of each treatment.
TEWL was measured at the same sites at 1, 3, 6, and 24 hours after
barrier disruption. Barrier disruption was done between 0700 and
0800hours and then the barrier recovery rate was evaluated
immediately to avoid the effect of circadian rhythm (Denda and
Tsuchiya, 2000b). The barrier recovery results are expressed as
percent recovery, because of the day-to-day variations in the extent
of barrier disruption. In each animal, the percentage recovery was
calculated by the following formula: (TEWL immediately after barrier
disruption–TEWL at indicated time point)/(TEWL immediately after
barrier disruption—baseline TEWL) 100%. In our case, TEWL
immediately after barrier disruption was 7–10mg cm2 per hour, and
the baseline TEWL (before tape-stripping) was 0.10–0.15mg cm2
per hour.
Statistics
Data are presented as the mean±SD. The statistical significance of
the differences between the two groups was determined by t-test. For
more than two groups, significance was determined by analysis of
variance and Tukey’s test. P-values o0.05 were considered
statistically significant.
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